Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should Know

Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should Know

Bibliographic Details
Main Author: Felipe Martínez
Format: Article
Language:English
Published: Radcliffe Medical Media 2021-03-01
Series:European Cardiology Review
Online Access:https://www.ecrjournal.com/articleindex/ecr.2020.38
id doaj-d80ba3ca3c0d4fe485081691a10cf167
record_format Article
spelling doaj-d80ba3ca3c0d4fe485081691a10cf1672021-10-09T16:03:28ZengRadcliffe Medical MediaEuropean Cardiology Review 1758-37561758-37642021-03-011610.15420/ecr.2020.38Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should KnowFelipe Martínezhttps://www.ecrjournal.com/articleindex/ecr.2020.38
collection DOAJ
language English
format Article
sources DOAJ
author Felipe Martínez
spellingShingle Felipe Martínez
Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should Know
European Cardiology Review
author_facet Felipe Martínez
author_sort Felipe Martínez
title Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should Know
title_short Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should Know
title_full Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should Know
title_fullStr Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should Know
title_full_unstemmed Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should Know
title_sort novel pharmacological treatment of patients with type 2 diabetes and cardiovascular disease: what cardiologists and diabetologists should know
publisher Radcliffe Medical Media
series European Cardiology Review
issn 1758-3756
1758-3764
publishDate 2021-03-01
url https://www.ecrjournal.com/articleindex/ecr.2020.38
work_keys_str_mv AT felipemartinez novelpharmacologicaltreatmentofpatientswithtype2diabetesandcardiovasculardiseasewhatcardiologistsanddiabetologistsshouldknow
_version_ 1716830330344701952

Similar Items